SCHEMBL10069480

SCHEMBL10069480

CCC(=O)Nc1cccc(NC(=O)c2ccc(OC)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK9 Q9NPC2 2/20 0.74
NPC1 O15118 9/20 0.72
SMN1; SMN2 Q16637 8/20 0.72
RAB9A P51151 8/20 0.72
TP53 P04637 6/20 0.72
KMT2A Q03164 5/20 0.72
ALDH1A1 P00352 4/20 0.72
PKM P14618 1/20 0.72
NFKB1 P19838 1/20 0.68
NFKB2 Q00653 1/20 0.68
RELA Q04206 1/20 0.68
KCNK3 O14649 2/20 0.67
ADORA3 P0DMS8 1/20 0.65
MEN1 O00255 3/20 0.63
MAPK1 P28482 1/20 0.61
ALOX15 P16050 1/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 1/20 0.60
GAA P10253 1/20 0.60
CYP2D6 P10635 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL882790 0.89 KCNK9 (0.71) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL10069460 0.87 KMT2A (0.73) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL12228183 0.84 NPC1 (0.83) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL10069470 0.84 KCNK9 (0.81) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL4256368 0.84 NPC1 (1.00) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL10069964 0.83 SMN1; SMN2 (1.00) NPC1SMN1; SMN2RAB9ATP53KMT2A
SCHEMBL1141400 0.82 MTNR1B (0.81) NPC1SMN1; SMN2RAB9ATP53KMT2A
SCHEMBL19501651 0.82 KCNK9 (0.86) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL19337737 0.82 KCNK9 (0.76) KCNK9NPC1SMN1; SMN2RAB9ATP53
SCHEMBL259430 0.81 NPC1 (1.00) KCNK9NPC1SMN1; SMN2RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9422262-B2 Compounds and methods for treating diseases mediated by protease activated receptors THE BROAD INSTITUTE, INC. (US) 2016-08-23 US disclosed
US-9422262-B2 Compounds and methods for treating diseases mediated by protease activated receptors THE BROAD INSTITUTE, INC. (US) 2016-08-23 US disclosed
WO-2012040636-A2 COMPOUNDS AND METHODS FOR TREATING DISEASES MEDIATED BY PROTEASE ACTIVATED RECEPTORS THE BROAD INSTITUTE, INC. (US) 2012-03-29 WO disclosed